FDA Inorambidza Zvigadzirwa Zviviri zveVuse Mint Yakavhenekera Vaping

Musi waNdira 24, 2023, iyo US Chikafu neDrug Administration (FDA) yakapa Marketing Denial Order (MDO) yemaviri emhando yeVuse mint.e-fodyazvigadzirwa zvinotengeswa naRJ Reynolds Vapor, mubatsiri weBritish American Fodya.

Zvigadzirwa zviviri zvakarambidzwa kutengeswa zvinosanganisira Vuse Vibe Tank Menthol 3.0% uye Vuse CiroCartridgeMenthol 1.5%.Iyo kambani haibvumidzwe kutengesa kana kugovera zvigadzirwa muUS, kana vangave vari panjodzi yekutevedzwa kweFDA.Makambani anogona, zvisinei, kuendesa zvakare chikumbiro kana kuendesa chikumbiro chitsva chekugadzirisa zvakakanganisika muzvigadzirwa zviri pasi pekuraira kwekuramba kushambadzira.

Iyi inyaya yechipiri yekurambidza e-fodya zvigadzirwa zvemhando iyi mushure mekunge FDA yapa mutemo wekuramba kushambadzira kwechigadzirwa chine mint-flavored cheLogic Technology Development, inotsigira Japan Tobacco International, muna Gumiguru gore rapfuura.

Iyo FDA yakati manyorerwo ezvigadzirwa izvi haana kupa humbowo hwakasimba hwesainzi kuratidza kuti mabhenefiti angangoita evakuru vanoputa anodarika njodzi dzekushandiswa kwevechidiki.

Iyo FDA yakacherekedza kuti humbowo huripo hunoratidza kuti isiri-fodya inonakae-fodya, kusanganisira menthol flavorede-fodya, "njodzi dziri kuzivikanwa uye dzakakosha pakukwezva vechidiki, kutora, uye kushandisa."Kusiyana neizvi, data inoratidza kuti e-cigarettes inonaka-fodya haina kukwezva kwakafanana kune vechidiki uye naizvozvo haisi kuisa ngozi yakafanana.

Mukupindura, Fodya yeBritish American yakaratidza kusagutsikana nedanho reFDA uye vakati Reynolds achabva atsvaga kumiswa kwemutemo uye achatsvaga dzimwe nzira dzakakodzera dzekubvumidza Vuse kuti irambe ichipa zvigadzirwa zvayo pasina kukanganisa.

“Tinotenda kuti mishonga inopfungaira ine menthol yakakosha mukubatsira vanhu vakuru vanosvuta kuti vasiyane nefodya inobvira.Sarudzo yeFDA, kana ikabvumidzwa kuti itange kushanda, ichakuvadza pane kubatsira hutano hweveruzhinji, "mutauriri weBAT akadaro.Reynolds akakwidza chirevo chekuramba kushambadzira kweFDA, uye dare reUS rapa kurambidzwa.